|
|
|
|
|
Detail |
| hsa-miR-122a |
|
Causal |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Unspecified |
Real-time expression profiling of microRNA precursors in human cancer cell lines. |
2005 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Unspecified |
MicroRNAs: novel regulators involved in the pathogenesis of Psoriasis? |
2007 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Unspecified |
High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Unspecified |
Identification of metastasis-related microRNAs in hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Unspecified |
MicroRNA gene expression deregulation in human breast cancer. |
2005 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Causal |
Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. |
2005 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Causal |
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. |
2006 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Unspecified |
MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. |
2008 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Unspecified |
Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Causal |
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Causal |
MicroRNA-122a functions as a novel tumor suppressor downstream of adenomatous polyposis coli in gastrointestinal cancers. |
2009 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Unspecified |
Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD |
2009 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Unspecified |
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. |
2008 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Unspecified |
Primary biliary cirrhosis is associated with altered hepatic microRNA expression. |
2009 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|